
    
      The primary purpose of the BEST Study is to determine whether the safety and efficacy of
      coronary stent implantation using everolimus-eluting balloon expandable stents is not
      inferior to coronary artery bypass grafting for the treatment of multivessel coronary artery
      disease.
    
  